Overall, 74% of breast cancer cases are luminal type A, 12% are TNBC, 10% are luminal B, and 4% are HER2+ (HER2-enriched), with the distributions varying by race and ethnicity as reported by the American Cancer Society [7]. The gene discussed is ERBB2; the disease is breast carcinoma.